510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0016-2018Class II

Philips Healthcare Ingenuity Core X-Ray, Tomography, Computed These computed tomography x-ray systems are...

Philips North America LLC / initiated 2017-01-18 / Terminated / root cause: manufacturing process

Philips Electronics North America Corporation began a recall of Philips Healthcare Ingenuity Core X-Ray, Tomography, Computed These computed tomography x-ray systems are intended to produce cross-sectional images of the... on . FDA classified it as Class II and gives the reason as "During a bolus tracking procedure, no images were generated when the scan was completed, and the raw data file was not available for offline reconstruction. There is a discrepancy between the calculated reconstruction...". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0016-2018
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Philips North America LLC
Product
Philips Healthcare Ingenuity Core X-Ray, Tomography, Computed These computed tomography x-ray systems are intended to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data taken at different angles and planes.
Product code
JAK System, X-Ray, Tomography, Computed
Reason for recall
During a bolus tracking procedure, no images were generated when the scan was completed, and the raw data file was not available for offline reconstruction. There is a discrepancy between the calculated reconstruction length and the actual scan length that results in the inability to reconstruct raw data. The operator may choose to rescan the patient.
Root cause tag
manufacturing process
FDA root cause
Process design
Action
Philips will bring defect into compliance: 1. Will issue a customer notification letter. 2. Will provide a software update, at no cost to the customer. CDRH approves the CAP subject to the following conditions: 1.Notification of all dealers and purchasers is to be made within 15 working days of receipt of this letter in the manner specified in 21 CFR 1003.21 and 1003.22. This office and the Food and Drug Administration (FDA) district office coordinator noted below are to be included in the notification. 2. You will implement this CAP by April 30, 2018. If you need any further information or support concerning this issue, please contact your local Philips representative or the Customer Care Solutions Center at 1-800-722 9377. .
Quantity in commerce
US - 606
Distribution
USA (nationwide) Distribution
Product codes and lots
Software version 4.16

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0016-2018
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0015-2018Class IITerminatedFDA Mandated
Z-0016-2018Class IITerminatedFDA Mandated
Z-0017-2018Class IITerminatedFDA Mandated
Z-0018-2018Class IITerminatedFDA Mandated
Z-0019-2018Class IITerminatedFDA Mandated
Z-0020-2018Class IITerminatedFDA Mandated